The use of silver nanoparticles as a safe and effective cancer treatment is a challenging endeavor that calls for intricate research including biologists who can assess how these relatively novel systems affect human cells as well as physicists, chemists and engineers who build and manufacture nanoparticles. In terms of cytotoxicity and the capacity to harm cancerous cells, they are in touch with them. Future applications of silver in nanomedicine include antibacterial therapies, medication delivery, biosensor systems, medical and cellular imaging methods and anti-cancer therapy. Silver nanoparticles have the potential to be quite helpful in delivering anticancer medications and resolving some of the issues with traditional therapies. Silver nanoparticles can work in concert with anticancer medications and enable the use of lower dosages, according to analyses. As a result, these nanocarriers are less harmful to cells. It is anticipated that this field of study will grow in the upcoming years with a wider range of anticancer medications and further understanding of the behavior of nanosystems in vivo with regard to absorption, distribution, metabolism and excretion And Lastly, silver nanoparticles (AgNPs) have been established as a superior antibacterial agent to combat infection-causing bacteria both in vivo and in vitro. Both gram-positive and gram-negative bacteria, including those that are resistant to several drugs, are susceptible to the antibacterial properties of silver nanoparticles. Because of their characteristics, silver nanoparticles can be used in health and medical goods to cure or prevent infections.
Ajeel et al. (Wed,) studied this question.